Glenmark gets USFDA nod for contraceptive tablets

New Delhi, 20 November 2017:

Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Loestrin tablets used to prevent pregnancy.

"Glenmark Pharmaceuticals USA has been granted final approval by the US Food and Drug Administration (USFDA) for Hailey 24 Fe (Norethindrone Acetate and Ethinyl Estradiol tablets, USP and Ferrous Fumarate tablets), 1 mg/20 mcg, the generic version of Loestrin 1 24 Fe tablets, of Allergan Pharmaceuticals," the company said in a BSE filing today.

According to IQVIATM sales data for the 12 months to September 2017, the Loestrin 24 Fe tablets market achieved annual sales of approximately USD 96.7 million, Glenmark said.

The company's current portfolio consists of 128 products authorised for distribution at the US marketplace and 59 Abbreviated New Drug Applications (ANDA) pending approval with the USFDA.

The stock was trading at Rs 591, up 1.23 per cent, on the BSE. ETHealthWorld

BSF, DRI seize Phensedyl cough syrup worth over Rs 26 lakh

Shillong, Nov 17, 2017:

The BSF and Directorate of Revenue Intelligence (DRI) arrested two persons and seized cartons of banned cough syrup worth over Rs 26 lakh from a truck at Mawiong area, BSF officials said here today.

Acting on a tip-off, the BSF and the DRI intercepted the truck at Mawiong area in the outskirts of the city yesterday carrying 70 illegal cartons of Phensedyl cough syrup hidden in a pile of rice, they said.

According to the BSF spokesperson here, the consignment was meant to be smuggled to Bangladesh through international border at Tripura.

The two persons, driver and the helper, were apprehended and later arrested, the BSF official said.

A thorough investigation is on to identify those involved in the crime, the official added. PTI